Challenges & Solutions
Where truConsent makes the difference.
The challenge
Prescription data and purchase history are personal data
Online pharmacies and telehealth platforms collect diagnoses, prescriptions, and medication histories as part of providing the service. Using that data for remarketing, product recommendations, or third-party pharma partnerships requires separate consent — and most platforms don't have it structured that way.
truConsent
truConsent separates clinical consent from commercial consent at the point of data capture. Patients see exactly what each consent covers — and can withdraw the commercial layer without losing access to their care. Purpose-separated from day one.
The challenge
Patient consent for treatment doesn't cover anything else
Consent given for a consultation, test, or procedure doesn't extend to analytics, research, insurer data sharing, or wellness programmes. Each is a distinct DPDPA purpose. Most healthcare platforms have one consent touchpoint; the Act requires as many as there are uses of that data.
truConsent
truConsent's profile-based purpose architecture captures consent at the purpose level, not the interaction level. When a new use case is introduced, re-consent workflows target only the patients whose existing consent doesn't cover it — not a blanket campaign across your entire patient base.
The challenge
Children's health data needs verifiable parental consent for any secondary use
Treating a child doesn't require parental consent to proceed — but using that child's data for anything beyond the treatment does. Analytics, wellness tracking, vaccination registries, and research all sit outside the treatment exemption and require verified parental approval.
truConsent
truConsent's Verifiable Parental Consent workflows handle paediatric data with the right consent layer — distinguishing treatment data from secondary uses and routing parental verification where the Act requires it.
The challenge
Legacy patient data, no consent architecture
Hospitals and diagnostic chains hold years of patient records collected before DPDPA. That data is in active use — for analytics, outreach, research partnerships — without consent records that would survive regulatory scrutiny. Re-consenting a patient base of 500,000 across multiple data uses requires a system, not a spreadsheet.
truConsent
truConsent identifies which patient-purpose combinations lack valid consent and runs structured re-consent campaigns at scale — with configurable notice content, delivery channels, and full audit trails on every interaction.